KALINDI PATEL: Open Payments
NPI 1053018051 · WINTER GARDEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 17 payments from 9 companies in 2025. Trend: 2023 $516 · 2024 $724 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Alkermes, Inc. | 2 | $46 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Noven Therapeutics, LLC | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Neos Therapeutics, LP | 1 | $18 |
Products named: VRAYLAR, CAPLYTA, REXULTI, LYBALVI, SPRAVATO, Xelstrym, Auvelity, Qelbree.
Industry payments across FL — which companies pay providers there.
